A multi-centre, randomized, non-inferiority trial to compare ulipristal with standard surgical treatment in women with symptomatic uterine fibroids: Protocol of the MYOMEX-2 trial.

MLA

Middelkoop, Mei-An, et al. “A Multi-Centre, Randomized, Non-Inferiority Trial to Compare Ulipristal with Standard Surgical Treatment in Women with Symptomatic Uterine Fibroids: Protocol of the MYOMEX-2 Trial.” European Journal of Obstetrics & Gynecology & Reproductive Biology, vol. 256, Jan. 2021, pp. 63–69. EBSCOhost, https://doi.org/10.1016/j.ejogrb.2020.10.058.

APA

Middelkoop, M.-A., Huirne, J. A. F., van der Weide, M. C. J., Bosmans, J. E., Hehenkamp, W. J. K., & Myomex-2 Trial Group. (2021). A multi-centre, randomized, non-inferiority trial to compare ulipristal with standard surgical treatment in women with symptomatic uterine fibroids: Protocol of the MYOMEX-2 trial. European Journal of Obstetrics & Gynecology & Reproductive Biology, 256, 63–69. https://doi.org/10.1016/j.ejogrb.2020.10.058

Chicago

Middelkoop, Mei-An, Judith A.F. Huirne, Marijke C. Jansen van der Weide, Judith E. Bosmans, Wouter J.K. Hehenkamp, and Myomex-2 Trial Group. 2021. “A Multi-Centre, Randomized, Non-Inferiority Trial to Compare Ulipristal with Standard Surgical Treatment in Women with Symptomatic Uterine Fibroids: Protocol of the MYOMEX-2 Trial.” European Journal of Obstetrics & Gynecology & Reproductive Biology 256 (January): 63–69. doi:10.1016/j.ejogrb.2020.10.058.